Xylem (XYL) has drawn attention after reporting Q1 2026 earnings that came in above analyst expectations on both revenue and earnings per share, alongside an increase in full year revenue guidance.

Despite the earnings beat and higher revenue guidance, the recent 1 day share price return of 2.13% and 7 day return of 4.99% sit within a wider 90 day share price decline of 16.33% and a year to date share price return of 15.83%. The 3 year total shareholder return of 14.87% suggests longer term holders have seen a different experience compared with recent trading volatility.

If Xylem's recent moves have you thinking about where else capital might work hard in essential infrastructure, it could be worth scanning 32 power grid technology and infrastructure stocks

With Xylem trading around $115.40, showing a 16.3% decline over 90 days yet a positive 3 year total shareholder return of 14.87%, the key question is whether recent weakness signals an undervalued water leader or a market that is already pricing in future growth.

Most Popular Narrative: 24.5% Undervalued

At a last close of $115.40 against a narrative fair value of $152.82, Xylem is framed as trading at a sizeable discount and anchored to a long runway of water infrastructure demand and services driven earnings.

Successful post-acquisition integration of Evoqua and revenue synergies from services expansion are accelerating Xylem's shift toward more recurring, higher-margin aftermarket and services revenue streams, boosting earnings stability and long-term profitability.

Want to see what sits behind that services pivot and valuation gap? The narrative leans on steady revenue growth, rising margins, and a future earnings profile that assumes investor appetite for a premium P/E multiple. Curious which specific profit and buyback assumptions need to hold for that gap to close? The full story connects those moving parts into one valuation playbook.

Result: Fair Value of $152.82 (UNDERVALUED)

However, this hinges on funding and execution holding up, with any prolonged delays in government-backed water projects or integration missteps at Evoqua quickly challenging that upside story.

Another Take On Valuation

While the narrative fair value of $152.82 frames Xylem as undervalued, the current P/E of 28x sits slightly above the Machinery industry at 27.4x and the fair ratio of 27.2x. That gap points to some valuation risk. Is the premium a cushion or a tightrope for future expectations?

Next Steps

With mixed signals on valuation and sentiment, it helps to see the underlying data yourself and move quickly while the picture is fresh. To understand why some investors are optimistic about its potential rewards, take a closer look at the 5 key rewards

Looking for more investment ideas?

If Xylem has sharpened your thinking, do not stop there. Broaden your watchlist with other focused ideas that could suit your goals and risk appetite.

• Target reliable value by scanning companies that screen as attractively priced relative to fundamentals through the 53 high quality undervalued stocks.
• Strengthen your income stream by reviewing opportunities offering higher yields and resilient payouts using the 12 dividend fortresses.
• Prioritize resilience by filtering for companies with robust balance sheets and financial footing via the solid balance sheet and fundamentals stocks screener (45 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.